Effect of Fresh Gas Flow Differences on Postoperative Nausea and Vomiting
Effects of Different Fresh Gas Flow Applications on Postoperative Nausea and Vomiting in Septorhinoplasty Surgeries
1 other identifier
interventional
150
1 country
1
Brief Summary
The aim of this study is to investigate the effect of fresh gas flow applied during general anesthesia on the incidence of postoperative nausea and vomiting in patients undergoing septorhinoplasty surgery. Patients who agree to participate in the study will be divided into three groups according to the fresh gas flow applied: low flow (0.5 lt/min) (Group L), medium flow (2 lt/min) (Group M) and high flow (4 lt/min) (Group H), and the postoperative nausea and vomiting data of the groups will be compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2025
CompletedFirst Submitted
Initial submission to the registry
April 14, 2025
CompletedFirst Posted
Study publicly available on registry
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedJanuary 14, 2026
January 1, 2026
7 months
April 14, 2025
January 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
postoperative nausea and vomiting
The patients' postoperative nausea and vomiting scores will be assessed when they are taken to the postoperative care room, immediately before being transferred from the postoperative care room to the ward (at the 30th minute postoperatively), at the 1st hour postoperatively, at the 6th hour postoperatively, at the 12th hour postoperatively, and at the 24th hour postoperatively. Nausea will be assessed by scoring with a numerical rating scale between 0 and 10. Vomiting will be questioned. If vomiting occurs, the number of times it occurs will be questioned. Whether postoperative antiemetics are used and if so, how many mg are used will be recorded. If postoperative opioids are used, how many mg are used will be recorded.
24 hours
Secondary Outcomes (3)
intraoperative body temperature
intraoperative
Whether kidney functions are affected
1 hour postoperative
whether liver functions are affected
1 hour postoperative
Study Arms (3)
low flow anesthesia group
ACTIVE COMPARATORAfter endotracheal intubation, fresh gas flow will be applied at 4 lt/min for 8 minutes, and in the low-flow anesthesia group, it will be reduced to 0.5 lt/min and maintained at this flow throughout the surgery.
medium flow anesthesia group
ACTIVE COMPARATORAfter endotracheal intubation, fresh gas flow will be applied at 4 lt/min for 8 minutes, and in the medium-flow anesthesia group, it will be reduced to 2 lt/min and maintained at this flow throughout the surgery.
high flow anesthesia group
ACTIVE COMPARATORAfter endotracheal intubation, fresh gas flow will be applied at 4 lt/min for 8 minutes and then continued in the same manner (4 lt/min) in the high-flow anesthesia group.
Interventions
Fresh gas flow will be set to 0.5 l/min in the low flow anesthesia group.
Fresh gas flow will be set to 2 lt/min in the medium flow anesthesia group.
Fresh gas flow will be set to 4 lt/min in the high flow anesthesia group.
Eligibility Criteria
You may qualify if:
- Patients who agreed to participate in the study
- years of age
- ASA I-II risk group patients
You may not qualify if:
- Patient does not accept the study
- Presence of psychiatric disorder and patient's inability to cooperate
- Cognitive dysfunction
- Hearing problems
- History of alcohol or drug addiction
- Presence of a serious pre-existing medical condition that limits objective assessment
- Complications developed during surgery
- Presence of any life-threatening condition after surgery
- Patient's classification is ASA III-IV
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Adıyaman Training and Research Hospital
Adıyaman, Merkez, 02040, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Researchers who will evaluate postoperative nausea and vomiting and patients participating in the study will be blinded to the difference in fresh gas flow that will be applied to them.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist physician
Study Record Dates
First Submitted
April 14, 2025
First Posted
May 1, 2025
Study Start
March 10, 2025
Primary Completion
September 28, 2025
Study Completion
September 30, 2025
Last Updated
January 14, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share